UY31058A1 - Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios - Google Patents
Formulaciones de aminoacido n-halogenado con compuestos antiinflamatoriosInfo
- Publication number
- UY31058A1 UY31058A1 UY31058A UY31058A UY31058A1 UY 31058 A1 UY31058 A1 UY 31058A1 UY 31058 A UY31058 A UY 31058A UY 31058 A UY31058 A UY 31058A UY 31058 A1 UY31058 A1 UY 31058A1
- Authority
- UY
- Uruguay
- Prior art keywords
- amino acid
- halogenated amino
- inflammatory compounds
- acid formulations
- inflammatory compound
- Prior art date
Links
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 239000004469 amino acid formulation Substances 0.000 title 1
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 238000009472 formulation Methods 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 206010057190 Respiratory tract infections Diseases 0.000 abstract 1
- 230000000845 anti-microbial effect Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El presente invento se refiere a una formulacion con actividad antimicrobiana que contiene un aminoácido N-halogenado y un compuesto antiinflamatorio. Asimismo, la presente memoria describe métodos para el tratamiento de una infeccion de un tejido que comprende poner en contacto el tejido infectado con una cantidad farmacéuticamente eficaz de una formulacion que contiene un aminoácido N-halogenado y un compuesto antiinflamatorio. Asimismo, la presente memoria describe un método para el tratamiento de infecciones respiratorias que comprende poner en contacto el sitio infectado con una cantidad farmacéuticamente eficaz de una formulacion que contiene un aminoácido N-halogenado y un compuesto antiinflamatorio.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US91527707P | 2007-05-01 | 2007-05-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY31058A1 true UY31058A1 (es) | 2008-10-31 |
Family
ID=39495776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY31058A UY31058A1 (es) | 2007-05-01 | 2008-04-29 | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20080275122A1 (es) |
| EP (1) | EP2139519A1 (es) |
| JP (1) | JP2010526085A (es) |
| KR (1) | KR20100017159A (es) |
| CN (1) | CN101687041A (es) |
| AR (1) | AR066372A1 (es) |
| AU (1) | AU2008247788A1 (es) |
| BR (1) | BRPI0810962A2 (es) |
| CA (1) | CA2684186A1 (es) |
| CL (1) | CL2008001282A1 (es) |
| MX (1) | MX2009011818A (es) |
| RU (1) | RU2009144286A (es) |
| TW (1) | TW200901957A (es) |
| UY (1) | UY31058A1 (es) |
| WO (1) | WO2008137444A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2265267B1 (en) * | 2008-04-10 | 2016-09-21 | Waldemar Gottardi | Compositions comprising n-halogenated or n, n-dihalogenated amine for treatment and prophylaxis of bronchopulmonary infections |
| WO2009127924A1 (en) * | 2008-04-15 | 2009-10-22 | Waldemar Gottardi | Compositions and devices for antisepsis and anticoagulation |
| CN103747770A (zh) | 2011-06-15 | 2014-04-23 | Rls全球股份公司 | 龋牙本质组织的检测和除去 |
| SE536581C2 (sv) | 2012-07-24 | 2014-03-11 | Rls Global Ab | Ett kit för behandling av sår eller liknande och ett preparat och metoder därav |
| US20140227201A1 (en) * | 2013-02-13 | 2014-08-14 | Novabay Pharmaceuticals, Inc. | Antimicrobial Gel Formulations |
| KR102253324B1 (ko) * | 2019-11-27 | 2021-05-18 | 단디바이오사이언스 주식회사 | 호흡기 질환의 예방, 개선 또는 치료용 조성물 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| US5421818A (en) * | 1993-10-18 | 1995-06-06 | Inner Ear Medical Delivery Systems, Inc. | Multi-functional inner ear treatment and diagnostic system |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US6156728A (en) * | 1996-11-01 | 2000-12-05 | Genentech, Inc. | Treatment of inner ear hair cells |
| AU2001261748A1 (en) * | 2000-05-19 | 2001-12-03 | Alcon Laboratories Inc. | Antibiotic compositions for treatment of the eye, ear and nose |
| AR031135A1 (es) * | 2000-10-10 | 2003-09-10 | Upjohn Co | Composiciones de antibiotico topico para el tratamiento de infecciones oculares |
| WO2003061566A2 (en) * | 2002-01-24 | 2003-07-31 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Anti-cancer combination and use thereof |
| PL1656095T3 (pl) * | 2003-08-18 | 2014-04-30 | Novabay Pharmaceuticals Inc | N,n-dwuchlorowcowane kwasy aminowe i pochodne |
| TWI386201B (zh) * | 2005-01-25 | 2013-02-21 | Novabay Pharmaceuticals Inc | Ｎ-鹵化胺基酸、ｎ，ｎ-二鹵化胺基酸與其衍生物；以及使用其之組合物與方法 |
| UY31059A1 (es) * | 2007-05-01 | 2008-10-31 | Alcon Res Ltd | Formulaciones de aminoacido n-halogenado |
-
2008
- 2008-04-29 UY UY31058A patent/UY31058A1/es not_active Application Discontinuation
- 2008-04-30 AR ARP080101843A patent/AR066372A1/es not_active Application Discontinuation
- 2008-04-30 CA CA002684186A patent/CA2684186A1/en not_active Abandoned
- 2008-04-30 EP EP08780580A patent/EP2139519A1/en not_active Withdrawn
- 2008-04-30 CN CN200880013887A patent/CN101687041A/zh active Pending
- 2008-04-30 MX MX2009011818A patent/MX2009011818A/es unknown
- 2008-04-30 BR BRPI0810962-1A2A patent/BRPI0810962A2/pt not_active IP Right Cessation
- 2008-04-30 TW TW097115859A patent/TW200901957A/zh unknown
- 2008-04-30 KR KR1020097024160A patent/KR20100017159A/ko not_active Withdrawn
- 2008-04-30 JP JP2010506590A patent/JP2010526085A/ja not_active Withdrawn
- 2008-04-30 WO PCT/US2008/061956 patent/WO2008137444A1/en not_active Ceased
- 2008-04-30 RU RU2009144286/15A patent/RU2009144286A/ru not_active Application Discontinuation
- 2008-04-30 AU AU2008247788A patent/AU2008247788A1/en not_active Abandoned
- 2008-04-30 US US12/112,352 patent/US20080275122A1/en not_active Abandoned
- 2008-05-02 CL CL2008001282A patent/CL2008001282A1/es unknown
-
2010
- 2010-04-26 US US12/767,420 patent/US20100210730A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20100017159A (ko) | 2010-02-16 |
| CA2684186A1 (en) | 2008-11-13 |
| CN101687041A (zh) | 2010-03-31 |
| AR066372A1 (es) | 2009-08-12 |
| US20100210730A1 (en) | 2010-08-19 |
| BRPI0810962A2 (pt) | 2015-01-27 |
| MX2009011818A (es) | 2009-11-13 |
| CL2008001282A1 (es) | 2009-01-16 |
| EP2139519A1 (en) | 2010-01-06 |
| WO2008137444A1 (en) | 2008-11-13 |
| JP2010526085A (ja) | 2010-07-29 |
| US20080275122A1 (en) | 2008-11-06 |
| TW200901957A (en) | 2009-01-16 |
| RU2009144286A (ru) | 2011-06-10 |
| AU2008247788A1 (en) | 2008-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0414581C1 (pt) | composto, composição farmacêutica compreendendo o referido composto e uso do referido composto | |
| EA201101672A1 (ru) | Замещенные производные аминомасляной кислоты в качестве ингибиторов неприлизина | |
| CR20120190A (es) | INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA | |
| MD4577B1 (ro) | Compoziţii masticabile de uz veterinar care conţin agent activ izoxazolinic şi utilizarea acestora în tratamentul sau prevenirea unei infestări sau infecţii parazitare | |
| CY1117547T1 (el) | Ενωση πυραζολοκινολινης | |
| SV2009003299A (es) | Derivados de dihidropiridina de utilidad como inhibidores de la proteina quinasa | |
| MX343215B (es) | Composiciones farmacéuticas del compuesto espiro-oxindol para administración tópica y sus usos como agentes terapéuticos. | |
| UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
| UA110013C2 (uk) | Застосування композиції для лікування шарко-марі-тута і пов'язаних з нею розладів | |
| ECSP109984A (es) | Composición farmacéutica mejorada que contiene dihidropiridina, antagonista del canal de calcio y el método para su preparación | |
| NZ607580A (en) | N-heteroaryl compounds | |
| UY31058A1 (es) | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios | |
| EA201101621A1 (ru) | Производные бензоксазолона в качестве ингибиторов альдостеронсинтазы | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| UY33348A (es) | Compuestos de furopiridina y usos de los mismos | |
| TN2014000031A1 (en) | Use of organic compound for the treatment of noonan syndrome | |
| BRPI0920251A2 (pt) | composto, composição famacêutica, formulação, métodos para preparar o composto, um sal farmaceuticamente aceitável, para inibir o crescimento de um micróbio, para tratar um mamífero tendo uma infecção microbiana, e, uso de um composto. | |
| UY31059A1 (es) | Formulaciones de aminoacido n-halogenado | |
| EA201390345A1 (ru) | Терапевтическое болеутоляющее средство | |
| AR064152A1 (es) | Derivados de quinolina antibacterianos,composiciones farmaceuticas que los contienen y metodo de preparacion. | |
| BRPI0617655A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, ou um isômero óptico do mesmo, uso de um composto, e, formulação farmacêutica | |
| CO6290762A2 (es) | Nuevos derivados quinazolin-2, 4-diona y una composicion farmaceutica para prevenir a tratar la enfermedad neurocerebral | |
| MX2015010434A (es) | Derivados de acido bisfenil-butanoico sustituido como inhibidores de la endopeptidasa neutra (nep), con una mayor eficacia in vivo. | |
| UY31057A1 (es) | Formulaciones de aminoacido n-halogenado que contiene acido alifatico | |
| CO6660504A2 (es) | Agente terapeutico de liberacion sostenida para la hipertensión y la disfunción renal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RDES | Application refused |
Effective date: 20190815 |